{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Primary lymphoedema",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_bendroflumethiazide",
          "name": "Bendroflumethiazide"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_lymfactin",
          "name": "Lymfactin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_daltaparin",
          "name": "Daltaparin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_ciprofloxacin",
          "name": "Ciprofloxacin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_benzopyrone",
          "name": "Benzopyrone"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_tricyclic_antidepressants",
          "name": "Tricyclic antidepressants"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_pentoxifylline",
          "name": "Pentoxifylline"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_micronized_purified_flavonoid_fraction",
          "name": "Micronized purified flavonoid fraction"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_surgical_compression_devices",
          "name": "Surgical compression devices"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_mannitol",
          "name": "Mannitol"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_bendroflumethiazide",
          "type": "Target",
          "label": "OffTargetBendroflumethiazide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_bendroflumethiazide",
          "type": "Pathway",
          "label": "RiskPathwayBendroflumethiazide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_bendroflumethiazide",
          "type": "Phenotype",
          "label": "AdversePhenotypeBendroflumethiazide",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_bendroflumethiazide",
          "target": "n_ot_bendroflumethiazide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能激活旁路/离靶机制"
        },
        {
          "source": "n_ot_bendroflumethiazide",
          "target": "n_rp_bendroflumethiazide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路关联"
        },
        {
          "source": "n_rp_bendroflumethiazide",
          "target": "n_adv_bendroflumethiazide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_bendroflumethiazide",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消药物获益"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "疗效 vs 不良反应",
          "pro_nodes": [
            "n_ot_bendroflumethiazide"
          ],
          "con_nodes": [
            "n_adv_bendroflumethiazide"
          ],
          "note": "治疗效果与潜在不良反应之间的矛盾"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "可能导致电解质失衡，影响治疗效果",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "未识别长期使用的安全性问题，存在风险",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "Bendroflumethiazide 是否能有效渗透靶部位",
      "其作用路径是否与降水肿的机制相符"
    ],
    "falsification_tests": [
      "是否存在充分证据支持 Bendroflumethiazide 改善长期疗效？",
      "是否已有研究表明该药物在淋巴水肿中的具体适应性？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供关于药物安全性与疗效的更多数据",
      "分析冲突热点及其对综述结论的影响"
    ]
  }
}